New inhibitory signaling by CTLA-4

被引:0
|
作者
Christoph Wülfing
Helen M Tunbridge
David C Wraith
机构
[1] Christoph Wülfing,
[2] Helen M. Tunbridge and David C. Wraith are with the School of Cellular and Molecular Medicine,undefined
[3] University of Bristol,undefined
[4] Bristol,undefined
[5] UK.,undefined
来源
Nature Immunology | 2014年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
CTLA-4 is a potent inhibitor of T cell population expansion. The PIX-GIT2-PAK2 complex is recruited to the cytoplasmic domain of CTLA-4 via the kinase PKC-η, which suggests a previously unrecognized aspect of signal transduction via CTLA-4 in immunoregulation.
引用
收藏
页码:408 / 409
页数:1
相关论文
共 50 条
  • [21] Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
    Iwama, Shintaro
    De Remigis, Alessandra
    Callahan, Margaret K.
    Slovin, Susan F.
    Wolchok, Jedd D.
    Caturegli, Patrizio
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (230)
  • [22] CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance
    Romo-Tena, Jorge
    Gomez-Martin, Diana
    Alcocer-Varela, Jorge
    AUTOIMMUNITY REVIEWS, 2013, 12 (12) : 1171 - 1176
  • [23] The soluble CTLA-4 receptor: a new marker in autoimmune diseases
    Pawlak, E
    Kochanowska, IE
    Frydecka, I
    Kielbinski, M
    Potoczek, S
    Bilinska, M
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2005, 53 (04) : 336 - 341
  • [24] IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
    Azimnasab-Sorkhabi, Parviz
    Soltani-Asl, Maryam
    Yoshinaga, Tulio Teruo
    Massoco, Cristina de Oliveira
    Kfoury Junior, Jose Roberto
    IMMUNOLOGIC RESEARCH, 2023, 71 (05) : 679 - 686
  • [25] IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
    Parviz Azimnasab-sorkhabi
    Maryam Soltani-asl
    Túlio Teruo Yoshinaga
    Cristina de Oliveira Massoco
    Jose´ Roberto Kfoury Junior
    Immunologic Research, 2023, 71 : 679 - 686
  • [26] Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4
    Mo, Xuan
    Zhang, Hanghang
    Preston, Sarah
    Martin, Kayla
    Zhou, Bo
    Vadalia, Nish
    Gamero, Ana M.
    Soboloff, Jonathan
    Tempera, Italo
    Zaidi, M. Raza
    CANCER RESEARCH, 2018, 78 (02) : 436 - 450
  • [27] A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling
    Schneider, H
    Dias, SD
    Hu, H
    Rudd, CE
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (07) : 2042 - 2050
  • [28] Role of the CTLA-4 receptor in T cell activation and immunity - Physiologic function of the CTLA-4 receptor
    Scheipers, P
    Reiser, H
    IMMUNOLOGIC RESEARCH, 1998, 18 (02) : 103 - 115
  • [29] Ligand independent CTLA-4 can replace some but not all the functions of full length CTLA-4
    Araki, Manabu
    Chung, Denise
    Vijayakrishnan, Latitha
    Sobel, Raymond
    Oukka, Mohamed
    Wicker, Linda
    Sharpe, Arlene
    Kuchroo, Vijay
    CLINICAL IMMUNOLOGY, 2008, 127 : S110 - S111
  • [30] The role of cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling.
    Dias, SD
    Schneider, H
    Hu, H
    Rudd, CE
    BLOOD, 2001, 98 (11) : 509A - 509A